Axolbio/axolGEM iPSC-Derived Neural Stem Cells LRRK2 G2019S HOM/ax0310/1 Ea
细胞株
商品编号
ax0310
品牌
Axolbio
公司
Axolbio
公司分类
Human Cells
1 Ea
商品信息
axolGEM iPSC-Derived Neural Stem Cells LRRK2 G2019S HOM (1.5 million cells) and Neural Plating-XF Medium (30 mL)
Description:
Human iPSC-Derived Neural Stem Cells that have been genetically edited using CRISPR-Cas9 technology to introduce the G2019S mutation (GGC>AGC) in the
LRRK2
gene. This line is homozygous for the G2019S mutation so both alleles contain the mutation. Click on the product images to see the data and further details.?
The G2019S mutation in LRRK2 has been implicated in autosomal-dominant familial Parkinson's disease with late onset (Fonzo
et al
., 2006, Thaler
et al
., 2009). The G2019S mutation increases the kinase activity of LRRK2 causing increased autophosphorylation and substrate phosphorylation that may affect neuronal cell health in Parkinson's disease patients (West
et al
., 2005).?
Click here to see more data on Axol Neural Stem Cells
Product Specification:
Starting material
Dermal fibroblast
Donor gender
Female
Donor age at sampling
64 yrs
Karyotype
Normal
Reprogramming method
Episomal vector
Induction method
Monolayer & chemically defined medium
Genetic modification
Homozygous for the LRRK2 G2019S mutation (GGC>AGC)
Genetic modification
Contains a puromycin resistance cassette (intronic)
Size
≥1.5 million cells
Kit components
1 vial of axolGEM Neural Stem Cells (≥1.5 million cells) and 1 bottle of Plating-XF Medium (30 mL)
Growth properties
Adherent
Shipping conditions
Dry ice
Storage conditions
Liquid nitrogen
产品货号:14236.0